Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma. - Wikidata - awgldk - TriplyDB

Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma.

Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma.

http://www.wikidata.org/entity/Q37212916

about

Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation.

P2860

Q52910441-80068D85-1DA8-4C3C-B573-E7DDD1752CEC

P2860

Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma.

http://www.wikidata.org/entity/Q37212916

description

2013 թվականի հոկտեմբերի 2-ին հրատարակված գիտական հոդված

@hy

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

name

Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma.

@en

Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma.

@nl

type

label

Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma.

@en

Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma.

@nl

prefLabel

Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma.

@en

Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma.

@nl

P1433

Q37212916-756B0F5D-0279-4C90-944D-4385D62C55FA

P1476

Q37212916-2A8EFD11-1554-4E61-A509-D59B03E7F027

P2093

Q37212916-0F6A0959-61CF-41D7-AFE7-1E0CE8B5FBDC

Q37212916-11617B06-9121-4808-9D30-218B3AAB031C

Q37212916-3DA3A5D3-F5C9-4294-BACE-0322313DB923

Q37212916-631476D7-C9B8-4C25-980B-67D326E2252C

Q37212916-6AAE652A-6492-4386-94AC-F30FBAF97C21

Q37212916-DEF01FF2-C034-42BC-AEC8-10C0BC950A89

P2860

Q37212916-07DBB1D8-86E4-4569-9DBE-BBA6B27B084C

Q37212916-27923DB1-65CD-4CEB-A857-506744AE191C

Q37212916-357EEB1F-F3F6-4882-96A5-18D38623FEFA

Q37212916-36AB215D-2F63-4354-8594-330E7B35E550

Q37212916-5412E60A-4B47-4D4B-9359-146F70E1E374

Q37212916-5546B539-AE7D-4388-A936-1E9FE3B74086

Q37212916-66387BAE-387C-4746-B97D-0AEE3A1E72E6

Q37212916-70C17C62-9152-4A16-996F-2BD244713507

Q37212916-746B6725-ED03-4D30-9FF8-666F822122D2

Q37212916-77ED11C9-D4AF-427F-BCB4-CD8CFCE2E793

P304

Q37212916-002AB366-F66B-469E-9D8E-A4D36FC380A2

P31

Q37212916-5CA75864-B091-44DB-9608-0C3014BD1F1C

P356

Q37212916-9D09F18B-2D56-448C-8104-492E54767647

P433

Q37212916-93AB808B-AE2F-41FA-B620-9F2214F80DF1

P478

Q37212916-036D9379-9A8A-4AF3-B624-DC6DF5A12670

P577

Q37212916-AB78F852-8DD6-4628-AF90-C5F4EA33355F

P698

Q37212916-2E54AB6A-9E05-46A4-808E-5D6F43E5267F

P932

Q37212916-FDB14BBF-0389-41D6-87E5-E416D8151043

P356

J.EXPHEM.2013.09.012

P1433

Experimental Hematology

P1476

Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma.

@en

P2093

Bipin N Savani

http://www.w3.org/2001/XMLSchema#string

Brian G Engelhardt

http://www.w3.org/2001/XMLSchema#string

John P Greer

http://www.w3.org/2001/XMLSchema#string

Madan H Jagasia

http://www.w3.org/2001/XMLSchema#string

Nishitha M Reddy

http://www.w3.org/2001/XMLSchema#string

Olalekan Oluwole

http://www.w3.org/2001/XMLSchema#string

P2860

The evolving role of stem cell transplants in lymphomas

Hematopoietic SCT in Europe: data and trends in 2011.

Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies

High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry.

A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantatio

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.

Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.

Treatment options for transformed lymphoma: incorporating allogeneic stem cell transplantation in a multimodality approach.

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.

P304

39-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EXPHEM.2013.09.012

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24096123

http://www.w3.org/2001/XMLSchema#string

P932

5002948

http://www.w3.org/2001/XMLSchema#string